MISC

2014年11月

Fertility preservation in breast cancer patients

BREAST CANCER
  • Tadahiko Shien
  • ,
  • Mikiya Nakatsuka
  • ,
  • Hiroyoshi Doihara

21
6
開始ページ
651
終了ページ
655
記述言語
英語
掲載種別
DOI
10.1007/s12282-013-0463-5
出版者・発行元
SPRINGER JAPAN KK

Systemic therapies have been shown to effectively improve prognosis in patients with breast cancer. However, such therapies also become increasingly harmful as their duration increases, and they have adverse effects on fertility and ovarian function. Fertility preservation (FP) is important in young adult cancer survivors who may wish to have children. In Japan, some cancer societies recommend that the potentially serious effects of systemic therapy on ovarian function should be explained to women with cancer, and they should be encouraged to undergo FP prior to commencing treatment. Still, as there are no official guidelines, many oncologists lack the required knowledge and mind-set to advise young breast cancer patients on fertility issues. Counseling of patients and their families might improve their understanding about the influence of such treatment on fertility and ensure effective FP. There are several FP methods that can be selected before beginning treatment, and these methods have both advantages and disadvantages. Young adults with breast cancer who want to bear children in the future must be provided with FP counseling, in addition to advice about breast cancer treatment and prognosis.

リンク情報
DOI
https://doi.org/10.1007/s12282-013-0463-5
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000344347700003&DestApp=WOS_CPL
ID情報
  • DOI : 10.1007/s12282-013-0463-5
  • ISSN : 1340-6868
  • eISSN : 1880-4233
  • Web of Science ID : WOS:000344347700003

エクスポート
BibTeX RIS